Liangzhan G. Sun
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Targeting SPP1 requires moving beyond ligand blockade.
Journal: Cellular & molecular immunology
Published: May 25, 2026
Understanding nerve-tumor interactions: From basic biology to therapeutic innovation.
Journal: Genes & diseases
Published: July 12, 2025
An SPP1-SOCS1 pathway constrains interferon responses in tumor-associated macrophages and shapes an immunosuppressive tumor microenvironment.
Journal: Immunity
Published: May 07, 2025
ADAR1p110 promotes hepatocellular carcinoma metastasis via the miR-451a/TUBA1A axis.
Journal: Genes & diseases
Published: February 18, 2025
ADARp110 promotes hepatocellular carcinoma progression via stabilization of CD24 mRNA.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 14, 2025
ASH1L in Hepatoma Cells and Hepatic Stellate Cells Promotes Fibrosis-Associated Hepatocellular Carcinoma by Modulating Tumor-Associated Macrophages.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 02, 2024
UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma.
Journal: Cell death & disease
Published: December 06, 2022
Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor.
Journal: Oncogene
Published: May 12, 2021
PGC7 promotes tumor oncogenic dedifferentiation through remodeling DNA methylation pattern for key developmental transcription factors.
Journal: Cell death and differentiation
Published: April 28, 2020
Last Updated: 09/26/2026